Compare Organon Pharma Indonesia Tbk. (SCPI) vs Topindo Solusi Komunika Tbk. (TOSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Topindo Solusi Komunika Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Topindo Solusi Komunika Tbk. trades at Rp83 (market cap 363.15B, 18.52M 24h volume). The key difference: Topindo Solusi Komunika Tbk. is far larger — about 3.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TOSK | |
|---|---|---|
Market Cap | 104.4B | 363.15B |
Volume | — | 18.52M |
Lot | — | 185.2K |
Turnover | — | 1.51B |
Average Price | — | 81.67 |
Value | — | 1.51B |
Indicative Equilibrium Price | — | 83 |
Indicative Equilibrium Volume | — | 1.01K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Topindo Solusi Komunika Tbk.
PT Topindo Solusi Komunika Tbk (the Company) was established on March 21, 2018 based on the Notarial Deed of Barbara Bonardy Bong, S.H., No. 36. The Company commenced its commercial operation in 2019.
Read more on TOSK →
